Oral Microbiota and Oral Status of Adult Patients With Autism Spectrum Disorders (MICAA: MICrobiota Autism Adults)

Sponsor
Central Hospital, Nancy, France (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05910424
Collaborator
(none)
40
1
24

Study Details

Study Description

Brief Summary

The goals of this pilot study are to assess the presence of harmful germs for gums and to assess oral health in adults with autism spectrum disorder.

Condition or Disease Intervention/Treatment Phase
  • Other: collection of saliva, gum fluid and/or dental plaque samples
N/A

Detailed Description

Participants or their tutors will fulfill a form with general health information and daily habits.

Investigators will :
  • collect saliva, gum fluid and/ or dental plaque to characterise germs

  • assess gum health and oral hygiene

  • register decays, filled and missing teeth.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Pilot study concerning adults with autism spectrum disorderPilot study concerning adults with autism spectrum disorder
Masking:
None (Open Label)
Masking Description:
No Treatment
Primary Purpose:
Diagnostic
Official Title:
Characterisation of the Oral Microbiota and Oral Status of a Population of Adult Patients With Autism Spectrum Disorders: a Pilot Study
Anticipated Study Start Date :
Jul 1, 2023
Anticipated Primary Completion Date :
Aug 1, 2023
Anticipated Study Completion Date :
Jul 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Adults with Autism Spectrum Disorder

Adults with autism spectrum disorder Aged between 18 and 60 years old Dental cares and follow-up in Nancy hospital

Other: collection of saliva, gum fluid and/or dental plaque samples
Non-invasive sampling of dental plaque, crevicular fluid and/or saliva, using an examination probe, paper tips and saliva swabs

Outcome Measures

Primary Outcome Measures

  1. Presence of periodontopathogenic bacteria (harmful for gums) [Collection on Day 1]

    Technique used = Polymerase Chain Reaction (PCR) Measure unit = Colony-Forming Unit (CFU)

Secondary Outcome Measures

  1. Assessment of the presence of parasites Entamoeba gingivalis subtype 1 (ST1) and subtype 2 (ST2) and Trichomonas tenax [Collection on Day 1]

    Technique = Polymerase Chain Reaction (PCR) Unit = Colony-Forming Unit (CFU)

  2. Assessment of the periodontal status of patients with Autism Spectrum Disorder [Day 1]

    Index used = the Dutch Periodontal Index 0 = minimum value, better outcome 4 = maximum value, worse outcome

  3. Assessment of the dental condition [Day 1]

    Dental data will be collected using the Decay-Missing-Filled/Teeth (DMFT) score 0 = minimum value, best outcome 28 = maximum value, worst outcome

  4. Assessment of oral hygiene [Day 1]

    Oral hygiene will be assessed using the Silness and Löe plaque index and the lifestyle questionnaire 0 = minimum value, best outcome 3 = maximum value, worst outcome

  5. Collection of data about lifestyle habits (oral and dental hygiene, diet, activity, etc.) and drug treatments that may influence the clinical parameters observed [Before samples collection and clinical examination]

    Data collection via a form fulfilled by the participant or the patient's legal guardian

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • A person (or legal representative) who has received full information about the organisation of the research and accept to participate and the use of his or her data.

  • Adult with autism spectrum disorder, men or women aged between 18 and 60.

  • Member of a social security scheme or beneficiary of a medical insurance

Exclusion Criteria:
  • Children under 18 with autism spectrum disorder

  • Use of medication or situations that may affect the microbiota (use of antibiotics, probiotics, steroidal or non-steroidal anti-inflammatory drugs in the last 3 months, strict mouth breathing)

  • Smoking

  • Very lingual position of the teeth hindering clinical assessment of the periodontium

  • Patients who have had periodontal treatment for less than 6 months

  • Persons covered by articles L. 1121-5 to L. 1121-7 and L1122-2 of the French Public

Health Code:
  • Pregnant women, women in labour or breast-feeding mothers

  • Persons deprived of their liberty by a judicial or administrative decision

  • Persons unable to give their consent

  • Person under psychiatric care by virtue of articles L. 3212-1 and L. 3213-1 of the Public Health Code

  • Minor (not emancipated)

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Central Hospital, Nancy, France

Investigators

  • Principal Investigator: Ludivine BERBE, CHRU Nancy

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
BERBE Ludivine, Dentist, University Hospital Assistant, Central Hospital, Nancy, France
ClinicalTrials.gov Identifier:
NCT05910424
Other Study ID Numbers:
  • 2023-A01024-41
First Posted:
Jun 18, 2023
Last Update Posted:
Jun 18, 2023
Last Verified:
Jun 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by BERBE Ludivine, Dentist, University Hospital Assistant, Central Hospital, Nancy, France
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 18, 2023